Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use
View Patent ↗Multifunctional compounds are provided that readily crosslink in situ to provide crosslinked biomaterials. The multifunctional compounds contain a single component having at least three reactive functional groups thereon, with the functional groups selected so as to be non-reactive in an initial environment and inter-reactive in a modified environment. Reaction of a plurality of the multifunctional compounds results in a three-dimensional crosslinked matrix. In one embodiment, a first functional group is nucleophilic, a second functional group is electrophilic, and at least one additional functional group is nucleophilic or electrophilic. Methods for preparing and using the multifunctional compounds, and kits including the multifunctional compounds are also provided. Exemplary uses for the multifunctional compounds include tissue augmentation, biologically active agent delivery, bioadhesion, and prevention of adhesions following surgery or injury.
1. A multifunctional compound having the structure of formula (I):
wherein:
n is an integer from 1-12, and when n is 2-12, each Z component may be different;
R is selected from hydrophilic polymers, hydrophobic polymers, amphiphilic polymers, C 2-14 hydrocarbyls, and heteroatom-containing C 2-14 hydrocarbyls;
X is a nucleophilic group, Y is an electrophilic group, and Z is an electrophilic or a nucleophilic group;
L 1 , L 2 , and L 3 are linking groups; and
p, q, and r are integers from 0-1;
wherein the compound is essentially non-reactive in an initial environment but is rendered reactive upon exposure to a modification in the initial environment that provides a modified environment such that a plurality of the multifunctional compounds inter-react in the modified environment to form a three-dimensional matrix.
2. The multifunctional compound of claim 1 , wherein the nucleophilic groups are selected from —NH 2 , —NHR 1 , —N(R 1 ) 2 , —SH, —OH, —COOH, —C 6 H 4 —OH, —H, —PH 2 , —PHR 1 , —P(R 1 ) 2 , —NH—NH 2 , —CO—NH—NH 2 , and —C 5 H 4 N, where R 1 is a hydrocarbyl group, and each R 1 may be the same or different.
3. The multifunctional compound of claim 1 , wherein the electrophilic groups are selected from —CO—Cl, —(CO)—O—(CO)—R a (where R a is an alkyl group), —CH═CH—CH═O, —CH═CH—C(CH 3 )═O, halo, —N═C═O, —N═C═S, —SO 2 CH═CH 2 , —O(CO)—C═CH 2 , —O(CO)—C(CH 3 )═CH 2 , —S—S—(C 5 H 4 N), —O(CO)—C(CH 2 CH 3 )═CH 2 , —CH═CH—C═NH, —COOH, —(CO)O—N(COCH 2 ) 2 , —CHO, —(CO)O—N(COCH 2 ) 2 —S(O) 2 OH, and —N(COCH) 2 .
4. The multifunctional compound of claim 1 , wherein the nucleophilic groups are sulfhydryl groups and the electrophilic groups are sulfhydryl-reactive groups.
5. The multifunctional compound of claim 4 wherein the sulfhydryl-reactive groups are selected from mixed anhydrides; ester derivatives of phosphorus; ester derivatives of p-nitrophenol, p-nitrothiophenol and pentafluorophenol; esters of substituted hydroxylamines, including N-hydroxyphthalimide esters, N-hydroxysuccinimide esters, N-hydroxysulfosuccinimide esters, and N-hydroxyglutarimide esters; esters of 1-hydroxybenzotriazole; 3-hydroxy-3,4-dihydro-benzotriazin-4-one; 3-hydroxy-3,4-dihydro-quinazoline-4-one; carbonylimidazole derivatives; acid chlorides; ketenes; and isocyanates.
6. The multifunctional compound of claim 4 , wherein the sulfhydryl-reactive groups are selected so as to form a thioester, imido-thioester, thioether, or disulfide linkage upon reaction with the sulfhydryl groups.
7. The multifunctional compound of claim 1 , wherein R is a hydrophilic polymer.
8. The multifunctional compound of claim 7 , wherein the hydrophilic polymer is a linear, branched, dendrimeric, hyperbranched, or star polymer.
9. The multifunctional compound of claim 8 , wherein the hydrophilic polymer is selected from polyalkylene oxides; polyols; poly(oxyalkylene)-substituted diols and polyols; polyoxyethylated sorbitol; polyoxyethylated glucose; poly(acrylic acids) and analogs and copolymers thereof; polymaleic acids; polyacrylamides; poly(olefinic alcohols); poly(N-vinyl lactams); polyoxazolines; polyvinylamines; and copolymers thereof.
10. The multifunctional compound of claim 9 , wherein the hydrophilic polymer is a poly(oxyalkylene)-substituted polyol selected from mono-, di- and tri-polyoxyethylated glycerol, mono- and di-polyoxyethylated propylene glycol, and mono- and di-polyoxyethylated trimethylene glycol, and tetra(oxyethylene)pentaerythritol.
11. A kit for use in medical applications, comprising:
(a) a plurality of a multifunctional compound;
(b) a first buffer solution having a pH within the range of about 1.0 to 5.5; and
(c) a second buffer solution having a pH within the range of about 6.0 to 11.0,
wherein the multifunctional compound has the structure of formula (I):
wherein:
n is an integer from 1-12, and when n is 2-12, each Z component may be different;
R is selected from hydrophilic polymers, hydrophobic polymers, amphiphilic polymers, C 2-14 hydrocarbyls, and heteroatom-containing C 2-14 hydrocarbyls;
X is a nucleophilic group, Y is an electrophilic group, and Z is an electrophilic or a nucleophilic group;
L 1 , L 2 , and L 3 are linking groups; and
p, q, and r are integers from 0-1;
wherein the nucleophilic and electrophilic groups are non-reactive in a dry environment but are rendered reactive upon exposure to an aqueous environment such that the components inter-react in the aqueous environment to form a three-dimensional matrix, and further wherein each component is packaged separately and admixed immediately prior to use.
12. The kit of claim 11 further comprising a biologically active agent.
13. The kit of claim 12 wherein the biologically active agent is packaged with the multifunctional compound.
14. The kit of claim 12 , wherein the biologically active agent is packaged as a solution with the first buffer, or packaged as a solution with the second buffer.
15. The kit of claim 12 wherein the biologically active agent is an anti-fibrotic agent.
16. The kit of claim 15 wherein the anti-fibrotic agent is a cell cycle inhibitor selected from the group consisting of taxanes, vinca alkoid, camptothecin, anthracycline, nitrosourea, folic acid antagonist, cytidine analogue, pyrimidine analogues, purine analogue, nitrogen mustard, mytomycin, alkyl sulfonate, benzamide, halogenated sugar, azaserine, or a derivative thereof.
17. The kit of claim 16 wherein the cell cycle inhibitor is paclitaxel or an analogue or derivative thereof.
18. A method of forming a three-dimensional matrix comprising the steps of:
(a) providing a plurality of a multifunctional compound; and
(b) rendering the nucleophilic and electrophilic groups reactive by exposing the multifunctional compound to an aqueous environment to effect inter-reaction; wherein said exposure comprises:
(i) dissolving the multifunctional compound in a first buffer solution having a pH within the range of about 1.0 to 5.5 to form a homogeneous solution, and
(ii) adding a second buffer solution having a pH within the range of about 6.0 to 11.0 to the homogeneous solution; and
(c) allowing a three-dimensional matrix to form;
wherein, the multifunctional compound has the structure of formula (I):
wherein:
n is an integer from 1-12, and when n is 2-12, each Z component may be different;
R is selected from hydrophilic polymers, hydrophobic polymers, amphiphilic polymers, C 2-14 hydrocarbyls, and heteroatom-containing C 2-14 hydrocarbyls;
X is a nucleophilic group, Y is an electrophilic group, and Z is an electrophilic or a nucleophilic group;
L 1 , L 2 , and L 3 are linking groups; and
p, q, and r are integers from 0-1;
wherein the nucleophilic and electrophilic groups are non-reactive in a dry environment but are rendered reactive upon exposure to an aqueous environment such that the components inter-react in the aqueous environment to form a three-dimensional matrix, and further wherein each component is packaged separately and admixed immediately prior to use.